Healing is a speci   c biological process related to the general phenomenon of growth and tissue regeneration and is a process generally affected by several systemic conditions or as detrimental side-effects of chemotherapy- and radiotherapy-induced @entity32 of the oral mucosa. The objectives of this study is to evaluate the novel chitosan based functional drug delivery systems, which can be successfully incorporated into "dual action bioactive restorative materials", capable of inducing in vitro improved wound healing prototype and containing an antibiotic, such as @entity8701 , krill oil as an antioxidant and @entity692 as a molecular bone scaffold, which is naturally present in bone and is reported to be successfully used in promoting bone integration when implanted as well as promoting healing. The hydrogels were prepared using a protocol as previously reported by us. The physico-chemical features, including @entity296 ( @entity296 ), release behaviors, stability of the therapeutic agent-antioxidant-chitosan, were measured and compared to the earlier reported chitosan-antioxidant containing hydrogels. Structural investigations of the reactive surface of the hydrogel are reported. Release of @entity8701 was investigated for all newly prepared hydrogels. Bio-adhesive studies were performed in order to assess the suitability of these designer materials. Free radical defense capacity of the biomaterials was evaluated using established in vitro model. The bio-adhesive capacity of the materials in the in vitro system was tested and quantified. It was found that the favorable synergistic effect of free radical built-in defense mechanism of the new functional materials increased sustainable bio-adhesion and therefore acted as a functional multi-dimensional restorative material with potential application in wound healing in vitro.

Evaluation of XXXX containing chitosan hydrogels as potential dual action bio-active restorative materials: in vitro approach.

@entity692 :: ('MESH:D017886', 'Chemical') :: ['hydroxyapatite'] @entity32 :: ('MESH:D007249', 'Disease') :: ['inflammation'] @entity296 :: ('MESH:D009202', 'Disease') :: ['surface morphology', 'SEM'] @entity8701 :: ('MESH:D009761', 'Chemical') :: ['nystatin']
@entity8701 :: (MESH:D009761,Chemical) :: ['nystatin']
